SecBot SecBot
144 ·Filed Jun 29, 2026

ANAB

ANAPTYSBIO, INC
BEARISH
Impact 6/10
Horizondays Processed4mo ago SEC0001950047-26-006580
Form 144, notice of proposed sale of securities
Actionable Insight ▼ Bearish

The sustained insider selling by an officer is a strong bearish signal. Monitor for upcoming earnings or pipeline updates that could trigger further downside.

DirectionBearish
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$67.50
T+0 close · Jun 29, 2026 · via day close
Latest settled
−24.79%
T+60 · $50.77
Vs SPY
−28.35%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 30 $67.50entry
  2. T+1 · 5mo ago −3.07%α −2.93% · $65.43
  3. T+5 · 4mo ago −7.69%α −8.29% · $62.31
  4. T+20 · 4mo ago −20.58%α −19.55% · $53.61
  5. T+60 · 8w ago −24.79%α −28.35% · $50.77
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Officer Dennis Mulroy filed a Form 144 to sell 9,476 shares (~$601K) of AnaptysBio, continuing a heavy selling pattern of over 300,000 shares in the past month. This persistent insider selling by a key officer is a bearish signal, suggesting potential negative catalysts ahead.

Key Facts

  • Officer Dennis Mulroy intends to sell 9,476 shares of common stock, estimated value $601,213.35.
  • Mulroy has sold over 300,000 shares in the past month (since May 15, 2026) across numerous transactions.
  • The proposed sale follows a stock option exercise, resulting in dilution and insider cash-out.
  • Filing date: June 29, 2026; broker: Morgan Stanley Smith Barney LLC.

Financial Impact

Proposed sale of $601K; cumulative insider selling in past month exceeds $15M based on transaction values listed.

dilutioninsider ownership

Risk Factors

  • Continued insider selling could pressure the stock price.
  • Potential negative catalyst (e.g., clinical trial setback, guidance miss) may be imminent.
  • High analyst bullishness (94% buy) contrasts with insider behavior, creating divergence risk.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-006580
Document: 0001950047-26-006580-index.html0001950047-26-006580
Document: 0001950047-26-006580.txt0001950047-26-006580

Track record

28 reports on ANAB

Performance horizon

9 of 18 bullish or bearish reports moved the stock their way by T+1. Best: +41.26% at T+60 after the Mar 3, 2026 report. 12 of 18 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $46.25 Now $45.73 −1.12% settles Nov 17
  2. Nov 12, 20264d ago Press Release Bearish 4/10 Entry $46.25 to $45.73 Now $45.73 +1.12% ▲ +1.12% −0.79% vs SPY
  3. Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $46.45 to $47.97 Now $45.73 −1.55% ▲ +3.27% +0.91% vs SPY
  4. Sep 21, 20268w ago Press Release Neutral 5/10 Entry $53.92 to $50.77 Now $45.73 −15.19% ▼ −5.84% −5.12% vs SPY
  5. Aug 12, 202613w ago Institutional Cluster Bullish 5/10 Entry $56.02 to $58.47 Now $45.73 −18.37% ▲ +4.37% +4.57% vs SPY
  6. Jun 29, 202620w ago 144 Bearish 6/10 Viewing Entry $67.50 to $65.43 Now $45.73 +32.25% ▲ +3.07% +2.93% vs SPY
  7. Jun 29, 202620w ago DEFA14A Neutral 2/10 Entry $67.50 to $65.43 Now $45.73 −32.25% ▼ −3.07% −2.93% vs SPY
  8. Jun 26, 202620w ago 144 Bearish 6/10 Entry $65.97 to $67.50 Now $45.73 +30.68% ▼ −2.32% −1.54% vs SPY
  9. Jun 22, 202621w ago 8-K Neutral 2/10 Entry $59.43 to $58.48 Now $45.73 −23.05% ▼ −1.60% −1.55% vs SPY
  10. Jun 17, 202621w ago 144 Bearish 5/10 Entry $57.51 to $59.99 Now $45.73 +20.48% ▼ −4.31% −4.63% vs SPY
Showing 10 of 28

US Market Status

Market Closed · Opens in 6h 35m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 3, 2026